Trulieve closes US$60 million private placement of 10.5% Senior Secured Notes

Trulieve Cannabis Corp., a prominent cannabis company in the United States, recently announced the completion of a second tranche of a private placement offering of 10.5% Senior Secured Notes due 2030. The company closed this offering, raising US$60 million, following a previous offering that closed just a month before, bringing the total amount raised to US$200 million. The Notes were issued at a price of US$1,000 along with accrued interest from December 17, 2025, to January 29, 2026.

The Offering was carried out through an agency agreement with Canaccord Genuity Corp., who acted as the sole agent and bookrunner. After a statutory hold period in Canada, the Company plans to list the Notes on the Canadian Securities Exchange (CSE). The net proceeds from this Offering will be utilized for capital expenditures and general corporate purposes. It is important to note that the sale of these Notes has not been registered under the Securities Act of 1933 or any other jurisdiction, and this announcement is not an offer to sell or solicitation to buy the Notes in any unlawful state or jurisdiction.

This news release contains forward-looking statements regarding the Company’s plans for the net proceeds, listing of the Notes, and future matters. The use of words like “expects,” “continues,” “will,” “anticipates,” and “intends” is intended to indicate these forward-looking intentions. These statements are based on the Company’s current expectations, assumptions, and analysis of possible risks and factors that may impact future events. Actual events and results may differ significantly from these forward-looking statements due to various risks and uncertainties discussed in the Company’s filings with the United States Securities and Exchange Commission and SEDAR.

Overall, readers are encouraged to conduct their own assessment of the risks and uncertainties associated with this forward-looking information and not rely solely on the statements indicated here. The Company disclaims any obligation to update or revise the forward-looking information provided, emphasizing the importance of evaluating the reasons behind any discrepancies between the projected and actual results.